Analyst Ratings For GlaxoSmithKline PLC (NYSE:GSK)
Today, Citigroup Inc. reiterated its Neutral rating on GlaxoSmithKline PLC (NYSE:GSK).
There are 1 sell rating, 7 hold ratings, 10 buy ratings on the stock.
The current consensus rating on GlaxoSmithKline PLC (NYSE:GSK) is Buy (Score: 2.50) with a consensus target price of $45.67 per share, a potential 11.79% upside.
Some recent analyst ratings include
- 7/27/2017-Citigroup Inc. Reiterated Rating of Neutral.
- 7/24/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 5/26/2017-Berenberg Bank Upgrade from a “Hold ” rating to a ” Buy” rating.
- 4/5/2017-Exane BNP Paribas Upgrade from a “Underperform ” rating to a ” Neutral” rating.
- 3/9/2017-Liberum Capital initiated coverage with a Buy rating.
- 3/9/2017-Kepler Capital Markets initiated coverage with a Reduce rating.
Dividend information for GlaxoSmithKline PLC (NYSE:GSK)
GlaxoSmithKline PLC (NYSE:GSK) pays an annual dividend of Community Ranking: with a yield of 4.75% and an average dividend growth of -3.10% based on a 3 Year Average.
Dividend History for GlaxoSmithKline PLC (NYSE:GSK)
- On 7/26/2017 GlaxoSmithKline PLC announced a Quarterly dividend of $0.49 with an ex dividend date of 8/9/2017 which will be payable on 10/12/2017.
- On 4/26/2017 GlaxoSmithKline PLC announced a quarterly dividend of $0.48 4.79% with an ex dividend date of 5/10/2017 which will be payable on 7/13/2017.
- On 2/8/2017 GlaxoSmithKline PLC announced a quarterly dividend of $0.57 5.76% with an ex dividend date of 2/22/2017 which will be payable on 4/13/2017.
- On 10/26/2016 GlaxoSmithKline PLC announced a dividend of $0.46 with an ex dividend date of 11/2/2016 which will be payable on 1/12/2017.
- On 7/27/2016 GlaxoSmithKline PLC announced a dividend of $0.49 with an ex dividend date of 8/10/2016 which will be payable on 10/13/2016.
- On 4/28/2016 GlaxoSmithKline PLC announced a dividend of $0.55 with an ex dividend date of 5/11/2016 which will be payable on 7/14/2016.
- On 10/28/2015 GlaxoSmithKline PLC announced a dividend of $0.58 with an ex dividend date of 11/10/2015 which will be payable on 1/14/2016.
Recent Insider Trading Activity For GlaxoSmithKline PLC (NYSE:GSK)
GlaxoSmithKline PLC (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 8.98%.
- On 10/24/2016 Plc Glaxosmithkline, Major Shareholder, bought 66,500 with an average share price of $14.00 per share and the total transaction amounting to $931,000.00. View SEC Filing
Recent Trading Activity for GlaxoSmithKline PLC (NYSE:GSK)
Shares of GlaxoSmithKline PLC closed the previous trading session at 40.71 down -0.14 -0.34% with 4,652,408 shares trading hands.